» Articles » PMID: 38296982

Incorporating Longitudinal History of Risk Factors into Atherosclerotic Cardiovascular Disease Risk Prediction Using Deep Learning

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jan 31
PMID 38296982
Authors
Affiliations
Soon will be listed here.
Abstract

It is increasingly clear that longitudinal risk factor levels and trajectories are related to risk for atherosclerotic cardiovascular disease (ASCVD) above and beyond single measures. Currently used in clinical care, the Pooled Cohort Equations (PCE) are based on regression methods that predict ASCVD risk based on cross-sectional risk factor levels. Deep learning (DL) models have been developed to incorporate longitudinal data for risk prediction but its benefit for ASCVD risk prediction relative to the traditional Pooled Cohort Equations (PCE) remain unknown. Our study included 15,565 participants from four cardiovascular disease cohorts free of baseline ASCVD who were followed for adjudicated ASCVD. Ten-year ASCVD risk was calculated in the training set using our benchmark, the PCE, and a longitudinal DL model, Dynamic-DeepHit. Predictors included those incorporated in the PCE: sex, race, age, total cholesterol, high density lipid cholesterol, systolic and diastolic blood pressure, diabetes, hypertension treatment and smoking. The discrimination and calibration performance of the two models were evaluated in an overall hold-out testing dataset. Of the 15,565 participants in our dataset, 2170 (13.9%) developed ASCVD. The performance of the longitudinal DL model that incorporated 8 years of longitudinal risk factor data improved upon that of the PCE [AUROC: 0.815 (CI 0.782-0.844) vs 0.792 (CI 0.760-0.825)] and the net reclassification index was 0.385. The brier score for the DL model was 0.0514 compared with 0.0542 in the PCE. Incorporating longitudinal risk factors in ASCVD risk prediction using DL can improve model discrimination and calibration.

Citing Articles

Transforming Cardiovascular Risk Prediction: A Review of Machine Learning and Artificial Intelligence Innovations.

Kasartzian D, Tsiampalis T Life (Basel). 2025; 15(1).

PMID: 39860034 PMC: 11766472. DOI: 10.3390/life15010094.

References
1.
Wilkins J, Karmali K, Huffman M, Allen N, Ning H, Berry J . Data Resource Profile: The Cardiovascular Disease Lifetime Risk Pooling Project. Int J Epidemiol. 2015; 44(5):1557-64. PMC: 4707197. DOI: 10.1093/ije/dyv150. View

2.
Ridker P, Danielson E, Fonseca F, Genest J, Gotto Jr A, Kastelein J . Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359(21):2195-207. DOI: 10.1056/NEJMoa0807646. View

3.
Berry J, Dyer A, Cai X, Garside D, Ning H, Thomas A . Lifetime risks of cardiovascular disease. N Engl J Med. 2012; 366(4):321-9. PMC: 3336876. DOI: 10.1056/NEJMoa1012848. View

4.
Mosca L, Barrett-Connor E, Wenger N . Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011; 124(19):2145-54. PMC: 3362050. DOI: 10.1161/CIRCULATIONAHA.110.968792. View

5.
DeFilippis A, Young R, Blaha M . Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. Ann Intern Med. 2015; 163(1):68-9. DOI: 10.7326/L15-5105-2. View